Bioset Xc
Regeneration Technologies
FDA Clearance Information
The bioset xc was cleared through the FDA 510k pathway on September 6, 2006. It is manufactured by Regeneration Technologies and classified as a Class 2 device under product code MBP.
What It Is
FDA-Cleared Indications
- Use in embolization procedures to occlude or reduce blood flow through targeted blood vessels.
- Use when selective vascular occlusion is needed to treat a patient’s diagnosed condition, as specified in the device labeling.
Clinical Applications
- Catheter-based embolization of selected abnormal blood vessels.
- Embolization of vascular lesions or malformations when vascular occlusion is clinically indicated.
- Selective reduction of blood flow to a targeted tissue region under imaging guidance.
Reported off-label uses
- Use of embolic microspheres for transarterial treatment of hypervascular tumors may be reported in clinical practice, but the specific indication should be confirmed against the device’s current labeling.
- Use in uterine fibroid embolization may be reported for embolic microsphere devices, but it should not be assumed to be an FDA-cleared indication for this specific product without reviewing its labeling.
Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.
Practical Considerations
- The operator must select the particle size and injection technique according to the target vessel size, blood-flow pattern, anatomy and intended degree of occlusion.
- Delivery requires a compatible catheter system and fluoroscopic or other appropriate imaging guidance; device compatibility should be confirmed before use.
- Avoid unintended embolization by assessing collateral vessels, arteriovenous shunting and flow direction before injection.
- Contraindications, warnings, handling instructions and MRI status should be checked in the current manufacturer labeling and instructions for use; the available FDA summary does not establish MRI safety.
- Embolization is permanent or long-lasting for the treated vascular bed, although recanalization, collateral blood flow or disease progression can occur.
Frequently Asked Questions
What is bioset xc used for?
The bioset xc is used for embolization procedures to block blood flow to specific areas, such as tumors or vascular malformations.
What specialties typically use this device?
Interventional radiologists primarily use this device in procedures requiring precise embolization.
What are the FDA-cleared indications?
The device is cleared for use in embolization procedures to treat conditions like tumors and vascular malformations by blocking blood vessels.